-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-1596 tablets and will conduct clinical trials in the near future.

Zhitongcaijing·09/22/2026 00:09:02
Listen to the news
Zhitong Finance App News, Hengrui Pharmaceutical (01276.HK) issued an announcement. Recently, the company's subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. received approval from the State Drug Administration to issue a “Drug Clinical Trial Approval Notice” for HRS-1596 tablets and will conduct clinical trials in the near future.